Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-02-14 5:20 pm Sale | 2021-12-31 | 13G | C4 Therapeutics, Inc. CCCC | Perceptive Advisors LLC | 2,208,913 4.500% | -949,653 (-30.07%) | Filing History |
| 2022-02-14 5:18 pm Sale | 2021-12-31 | 13G | Rocket Pharmaceuticals, Inc. RCKT | Perceptive Advisors LLC | 1,959,125 3.000% | -1,437,742 (-42.33%) | Filing History |
| 2022-02-14 5:18 pm Sale | 2021-12-31 | 13G | Provention Bio, Inc. PRVB | Perceptive Advisors LLC | 948,481 1.500% | -2,684,542 (-73.89%) | Filing History |
| 2022-02-14 5:15 pm Unchanged | 2021-12-31 | 13G | Research Alliance Corp. II RACB | Perceptive Advisors LLC | 1,000,000 6.500% | 0 (Unchanged) | Filing History |
| 2022-02-14 5:11 pm Sale | 2021-12-31 | 13G | Rain Enhancement Technologies Holdco Inc RAIN | Perceptive Advisors LLC | 2,483,619 9.400% | -53,400 (-2.10%) | Filing History |
| 2022-02-14 5:05 pm Unchanged | 2021-12-31 | 13G | Forte Biosciences, Inc. FBRX | Perceptive Advisors LLC | 0 0.000% | 0 (Unchanged) | Filing History |
| 2022-02-14 4:57 pm Sale | 2021-12-31 | 13G | IsoPlexis Corporation ISO | Perceptive Advisors LLC | 4,875,530 12.300% | -31,342 (-0.64%) | Filing History |
| 2022-02-14 4:50 pm Sale | 2021-12-31 | 13G | Travere Therapeutics, Inc. TVTX | Perceptive Advisors LLC | 1,845,555 3.000% | -1,648,052 (-47.17%) | Filing History |
| 2022-02-14 4:48 pm Sale | 2021-12-31 | 13G | Prometheus Biosciences, Inc. RXDX | Perceptive Advisors LLC | 3,172,785 8.100% | -141,247 (-4.26%) | Filing History |
| 2022-02-14 4:40 pm Purchase | 2021-12-31 | 13G | BELLUS Health Inc. BLU | Perceptive Advisors LLC | 7,645,234 7.400% | 2,903,880 (+61.25%) | Filing History |
| 2022-02-14 4:38 pm Purchase | 2021-12-31 | 13G | enVVeno Medical Corporation NVNO | Perceptive Advisors LLC | 954,248 9.900% | 954,248 (New Position) | Filing History |
| 2022-02-14 4:10 pm Unchanged | 2021-12-31 | 13G | Albireo Pharma, Inc. ALBO | Perceptive Advisors LLC | 2,360,139 12.200% | 0 (Unchanged) | Filing History |
| 2022-02-14 4:01 pm Sale | 2021-12-31 | 13G | Neptune Wellness Solutions Inc. NEPT | Perceptive Advisors LLC | 7,183 6.000% | -8,685 (-54.73%) | Filing History |
| 2022-02-14 3:57 pm Purchase | 2021-12-31 | 13G | Agile Therapeutics, Inc. AGRX | Perceptive Advisors LLC | 10,647 17.500% | 2,687 (+33.76%) | Filing History |
| 2022-02-14 3:54 pm Purchase | 2021-12-31 | 13G | Verrica Pharmaceuticals Inc. VRCA | Perceptive Advisors LLC | 361,041 13.100% | 20,000 (+5.86%) | Filing History |
| 2022-02-14 3:50 pm Sale | 2021-12-31 | 13G | Global Blood Therapeutics, Inc. GBT | Perceptive Advisors LLC | 3,449,915 5.400% | -2,224,796 (-39.21%) | Filing History |
| 2022-02-14 3:50 pm Unchanged | 2021-12-31 | 13G | Athenex, Inc. ATNX | Perceptive Advisors LLC | 676,623 12.400% | 0 (Unchanged) | Filing History |
| 2022-02-14 3:48 pm Purchase | 2021-12-31 | 13G | Iovance Biotherapeutics, Inc. IOVA | Perceptive Advisors LLC | 10,127,941 6.500% | 961,637 (+10.49%) | Filing History |
| 2022-02-14 3:46 pm Unchanged | 2021-12-31 | 13G | Concert Pharmaceuticals, Inc. CNCE | Perceptive Advisors LLC | 2,150,641 6.200% | 0 (Unchanged) | Filing History |
| 2022-02-14 3:45 pm Purchase | 2021-12-31 | 13G | Amicus Therapeutics, Inc. FOLD | Perceptive Advisors LLC | 26,559,443 9.500% | 1,447,395 (+5.76%) | Filing History |